These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [What is the present status of the common virus vaccines?]. Regnard J Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188 [No Abstract] [Full Text] [Related]
3. Monitoring vaccines for human oncogenicity. Miller RW Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436 [No Abstract] [Full Text] [Related]
4. [Possibilities and limits of vaccinations]. Schneeweiss B Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862 [No Abstract] [Full Text] [Related]
5. Clinical experience with vaccines produced in the human diploid cell line WI-38. Andzaparidze OG Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367 [No Abstract] [Full Text] [Related]
6. Impotency of live-virus vaccines as a result of improper handling in clinical practice. Krugman RD; Meyer BC; Enterline JC; Parkman PD; Witte JJ; Meyer HM J Pediatr; 1974 Oct; 85(4):512-4. PubMed ID: 4443859 [No Abstract] [Full Text] [Related]
7. [Viral vaccines and local immunity]. Norrby E Lakartidningen; 1979 Oct; 76(40):3404-7. PubMed ID: 502677 [No Abstract] [Full Text] [Related]
8. December, 1994. New vaccine information statements. Md Med J; 1994 Dec; 43(12):1101-12. PubMed ID: 7815915 [No Abstract] [Full Text] [Related]
9. Benefits, risks and costs of viral vaccines. Koplan JP; Axnick NW Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868 [No Abstract] [Full Text] [Related]